Stock BVX BIVICTRIX THERAPEUTICS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Insiders BiVictriX Therapeutics Plc

Equities

BVX

GB00BNXH3K91

Market Closed - London S.E.
Other stock markets
 11:35:20 2024-06-03 am EDT 		5-day change 1st Jan Change
11.5 GBX 0.00% Intraday chart for BiVictriX Therapeutics Plc +4.55% +9.52%
May. 31 EARNINGS AND TRADING: CT UK High Income tops benchmark, ups dividend AN
Apr. 17 Bivictrix granted FDA orphan drug status for rare cancer treatment AN

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Bivictrix Therapeutics plc Announces Resignation of Iain Ross from the Board
CI
BiVictriX patent boost; 4Global deal extended
AN
Bivictrix hires new CFO as Alex Hughes steps down after seven months
AN
BiVictriX Therapeutics Appoints New CFO, Chief Business Officer
MT
BiVictriX Therapeutics Plc Appoints Adrian Howd as Chief Business Officer
CI
AEW UK REIT appoints new chair; Oberon raises money
AN
Bivictrix Therapeutics hails positive data in final leukaemia study
AN
EXECUTIVE CHANGES: Record founder retires; Bivictrix appoints new CFO
AN
BiVictriX Therapeutics CFO to Depart in March; Successor Named
MT
Bivictrix promotes non-executive director to non-executive chair
AN
BiVictriX Therapeutics Names Successor as Chairman Steps Down
MT
BiVictriX Therapeutics Plc Announces Board Changes
CI
BiVictriX Therapeutics plc Announces Appointment of Michael Kauffman as Independent Non-Executive Director
CI
BiVictriX Therapeutics Appoints New CFO
MT
BiVictriX Therapeutics Plc Appoints Glyn Baker as Chief Financial Officer, in A Non-Board Role
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BVX Stock
  4. News BiVictriX Therapeutics Plc
  5. Insiders